nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A7—Rifampicin—leprosy	0.116	0.147	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.116	0.147	CbGbCtD
Fentanyl—CYP3A7—Dapsone—leprosy	0.0959	0.121	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0959	0.121	CbGbCtD
Fentanyl—CYP3A5—Thalidomide—leprosy	0.09	0.114	CbGbCtD
Fentanyl—CYP3A5—Rifampicin—leprosy	0.0872	0.11	CbGbCtD
Fentanyl—CYP3A5—Dapsone—leprosy	0.0719	0.0908	CbGbCtD
Fentanyl—ABCB1—Rifampicin—leprosy	0.0567	0.0716	CbGbCtD
Fentanyl—CYP3A4—Rifampicin—leprosy	0.034	0.0429	CbGbCtD
Fentanyl—CYP3A4—Dapsone—leprosy	0.0281	0.0354	CbGbCtD
Fentanyl—Sick sinus syndrome—Thalidomide—leprosy	0.00763	0.0367	CcSEcCtD
Fentanyl—Hypoalbuminaemia—Dapsone—leprosy	0.00716	0.0344	CcSEcCtD
Fentanyl—Footdrop—Thalidomide—leprosy	0.00694	0.0334	CcSEcCtD
Fentanyl—Peroneal nerve palsy—Thalidomide—leprosy	0.00591	0.0284	CcSEcCtD
Fentanyl—Anxiety depression—Thalidomide—leprosy	0.00488	0.0234	CcSEcCtD
Fentanyl—Application site pain—Dapsone—leprosy	0.00355	0.0171	CcSEcCtD
Fentanyl—Mental status changes—Thalidomide—leprosy	0.0034	0.0163	CcSEcCtD
Fentanyl—Application site reaction—Dapsone—leprosy	0.00333	0.016	CcSEcCtD
Fentanyl—Swelling face—Dapsone—leprosy	0.00328	0.0158	CcSEcCtD
Fentanyl—Lymphoedema—Thalidomide—leprosy	0.00328	0.0158	CcSEcCtD
Fentanyl—Peritonitis—Thalidomide—leprosy	0.00317	0.0152	CcSEcCtD
Fentanyl—Hypoproteinaemia—Thalidomide—leprosy	0.00272	0.0131	CcSEcCtD
Fentanyl—Lacrimal structural disorder—Thalidomide—leprosy	0.00272	0.0131	CcSEcCtD
Fentanyl—Intestinal perforation—Thalidomide—leprosy	0.00203	0.00973	CcSEcCtD
Fentanyl—Dysaesthesia—Thalidomide—leprosy	0.00185	0.00889	CcSEcCtD
Fentanyl—Lacrimal disorder—Thalidomide—leprosy	0.00179	0.0086	CcSEcCtD
Fentanyl—Proteinuria—Dapsone—leprosy	0.00178	0.00855	CcSEcCtD
Fentanyl—Ascites—Thalidomide—leprosy	0.00176	0.00846	CcSEcCtD
Fentanyl—Protein urine present—Dapsone—leprosy	0.00175	0.00843	CcSEcCtD
Fentanyl—Altered state of consciousness—Thalidomide—leprosy	0.00173	0.00833	CcSEcCtD
Fentanyl—Aphthous stomatitis—Thalidomide—leprosy	0.00171	0.0082	CcSEcCtD
Fentanyl—Paraesthesia oral—Thalidomide—leprosy	0.00171	0.0082	CcSEcCtD
Fentanyl—Neck stiffness—Thalidomide—leprosy	0.00168	0.00808	CcSEcCtD
Fentanyl—Grand mal convulsion—Thalidomide—leprosy	0.00168	0.00808	CcSEcCtD
Fentanyl—Cerebral ischaemia—Thalidomide—leprosy	0.00166	0.00796	CcSEcCtD
Fentanyl—Peripheral vascular disorder—Thalidomide—leprosy	0.00163	0.00784	CcSEcCtD
Fentanyl—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00156	0.00752	CcSEcCtD
Fentanyl—Nuchal rigidity—Thalidomide—leprosy	0.00154	0.00741	CcSEcCtD
Fentanyl—Hostility—Thalidomide—leprosy	0.00145	0.00695	CcSEcCtD
Fentanyl—Sexual dysfunction—Thalidomide—leprosy	0.00143	0.00686	CcSEcCtD
Fentanyl—Vesiculobullous rash—Thalidomide—leprosy	0.00143	0.00686	CcSEcCtD
Fentanyl—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00138	0.00662	CcSEcCtD
Fentanyl—Platelet count decreased—Thalidomide—leprosy	0.00135	0.00647	CcSEcCtD
Fentanyl—Enlargement abdomen—Thalidomide—leprosy	0.00133	0.00639	CcSEcCtD
Fentanyl—Deep vein thrombosis—Thalidomide—leprosy	0.00132	0.00632	CcSEcCtD
Fentanyl—Myasthenia—Thalidomide—leprosy	0.00127	0.00612	CcSEcCtD
Fentanyl—Oral candidiasis—Thalidomide—leprosy	0.00126	0.00606	CcSEcCtD
Fentanyl—Hypomagnesaemia—Thalidomide—leprosy	0.00126	0.00606	CcSEcCtD
Fentanyl—Tooth disorder—Thalidomide—leprosy	0.00123	0.00593	CcSEcCtD
Fentanyl—Intestinal obstruction—Thalidomide—leprosy	0.00117	0.00564	CcSEcCtD
Fentanyl—Liver disorder—Thalidomide—leprosy	0.00117	0.00564	CcSEcCtD
Fentanyl—Burning sensation—Thalidomide—leprosy	0.00115	0.00554	CcSEcCtD
Fentanyl—Hypercalcaemia—Thalidomide—leprosy	0.00115	0.00554	CcSEcCtD
Fentanyl—Cyanosis—Thalidomide—leprosy	0.00113	0.00543	CcSEcCtD
Fentanyl—Lung disorder—Thalidomide—leprosy	0.00113	0.00543	CcSEcCtD
Fentanyl—Psychotic disorder—Dapsone—leprosy	0.00111	0.00533	CcSEcCtD
Fentanyl—Stupor—Thalidomide—leprosy	0.00107	0.00515	CcSEcCtD
Fentanyl—Pleural effusion—Thalidomide—leprosy	0.00105	0.00502	CcSEcCtD
Fentanyl—Amblyopia—Thalidomide—leprosy	0.00104	0.00498	CcSEcCtD
Fentanyl—Skin ulcer—Thalidomide—leprosy	0.00103	0.00494	CcSEcCtD
Fentanyl—Nasopharyngitis—Dapsone—leprosy	0.00101	0.00488	CcSEcCtD
Fentanyl—Rash pustular—Thalidomide—leprosy	0.001	0.00482	CcSEcCtD
Fentanyl—Muscular weakness—Dapsone—leprosy	0.001	0.00481	CcSEcCtD
Fentanyl—Influenza—Dapsone—leprosy	0.000981	0.00471	CcSEcCtD
Fentanyl—Endocrine disorder—Thalidomide—leprosy	0.000966	0.00464	CcSEcCtD
Fentanyl—Apnoea—Thalidomide—leprosy	0.000944	0.00454	CcSEcCtD
Fentanyl—Vasodilation—Thalidomide—leprosy	0.000911	0.00438	CcSEcCtD
Fentanyl—Proteinuria—Thalidomide—leprosy	0.000911	0.00438	CcSEcCtD
Fentanyl—Vasodilation procedure—Thalidomide—leprosy	0.000911	0.00438	CcSEcCtD
Fentanyl—Accidental injury—Thalidomide—leprosy	0.000905	0.00435	CcSEcCtD
Fentanyl—Protein urine present—Thalidomide—leprosy	0.000898	0.00432	CcSEcCtD
Fentanyl—Musculoskeletal stiffness—Thalidomide—leprosy	0.000892	0.00429	CcSEcCtD
Fentanyl—Viral infection—Thalidomide—leprosy	0.000886	0.00426	CcSEcCtD
Fentanyl—Bone disorder—Thalidomide—leprosy	0.000886	0.00426	CcSEcCtD
Fentanyl—Skin discolouration—Thalidomide—leprosy	0.000886	0.00426	CcSEcCtD
Fentanyl—Cellulitis—Thalidomide—leprosy	0.00088	0.00423	CcSEcCtD
Fentanyl—Arthropathy—Thalidomide—leprosy	0.00088	0.00423	CcSEcCtD
Fentanyl—Hypocalcaemia—Thalidomide—leprosy	0.000874	0.0042	CcSEcCtD
Fentanyl—Thinking abnormal—Thalidomide—leprosy	0.000874	0.0042	CcSEcCtD
Fentanyl—Oliguria—Thalidomide—leprosy	0.000869	0.00417	CcSEcCtD
Fentanyl—Drug interaction—Thalidomide—leprosy	0.000863	0.00415	CcSEcCtD
Fentanyl—Neuropathy peripheral—Dapsone—leprosy	0.000857	0.00412	CcSEcCtD
Fentanyl—Bone pain—Thalidomide—leprosy	0.000836	0.00402	CcSEcCtD
Fentanyl—Sinusitis—Dapsone—leprosy	0.000821	0.00394	CcSEcCtD
Fentanyl—Gait disturbance—Thalidomide—leprosy	0.00082	0.00394	CcSEcCtD
Fentanyl—Coordination abnormal—Thalidomide—leprosy	0.000815	0.00392	CcSEcCtD
Fentanyl—Neck pain—Thalidomide—leprosy	0.00081	0.00389	CcSEcCtD
Fentanyl—Pulmonary embolism—Thalidomide—leprosy	0.0008	0.00385	CcSEcCtD
Fentanyl—Eructation—Thalidomide—leprosy	0.000786	0.00378	CcSEcCtD
Fentanyl—Pharyngitis—Dapsone—leprosy	0.000779	0.00375	CcSEcCtD
Fentanyl—Depressed level of consciousness—Thalidomide—leprosy	0.000773	0.00371	CcSEcCtD
Fentanyl—Candida infection—Thalidomide—leprosy	0.000764	0.00367	CcSEcCtD
Fentanyl—Neuropathy—Thalidomide—leprosy	0.000752	0.00361	CcSEcCtD
Fentanyl—Dry eye—Thalidomide—leprosy	0.000739	0.00355	CcSEcCtD
Fentanyl—Cramps of lower extremities—Thalidomide—leprosy	0.000735	0.00353	CcSEcCtD
Fentanyl—Tinnitus—Dapsone—leprosy	0.000732	0.00352	CcSEcCtD
Fentanyl—Oesophagitis—Thalidomide—leprosy	0.000731	0.00351	CcSEcCtD
Fentanyl—Rash maculo-papular—Thalidomide—leprosy	0.000728	0.0035	CcSEcCtD
Fentanyl—Hypertonia—Thalidomide—leprosy	0.000702	0.00337	CcSEcCtD
Fentanyl—Sepsis—Thalidomide—leprosy	0.000695	0.00334	CcSEcCtD
Fentanyl—Mental disability—Thalidomide—leprosy	0.000695	0.00334	CcSEcCtD
Fentanyl—Euphoric mood—Thalidomide—leprosy	0.000688	0.00331	CcSEcCtD
Fentanyl—Erythema—Dapsone—leprosy	0.000684	0.00328	CcSEcCtD
Fentanyl—Lymphadenopathy—Thalidomide—leprosy	0.000681	0.00327	CcSEcCtD
Fentanyl—Thrombophlebitis—Thalidomide—leprosy	0.000671	0.00323	CcSEcCtD
Fentanyl—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000668	0.00321	CcSEcCtD
Fentanyl—Gastroenteritis—Thalidomide—leprosy	0.000656	0.00315	CcSEcCtD
Fentanyl—Eczema—Thalidomide—leprosy	0.000647	0.00311	CcSEcCtD
Fentanyl—Vision blurred—Dapsone—leprosy	0.000644	0.0031	CcSEcCtD
Fentanyl—Injury—Thalidomide—leprosy	0.000632	0.00304	CcSEcCtD
Fentanyl—Libido decreased—Thalidomide—leprosy	0.000627	0.00301	CcSEcCtD
Fentanyl—Increased appetite—Thalidomide—leprosy	0.000618	0.00297	CcSEcCtD
Fentanyl—Amnesia—Thalidomide—leprosy	0.000618	0.00297	CcSEcCtD
Fentanyl—Dermatitis exfoliative—Thalidomide—leprosy	0.000616	0.00296	CcSEcCtD
Fentanyl—Vertigo—Dapsone—leprosy	0.000614	0.00295	CcSEcCtD
Fentanyl—Visual disturbance—Thalidomide—leprosy	0.000613	0.00295	CcSEcCtD
Fentanyl—Dermatitis bullous—Thalidomide—leprosy	0.000608	0.00292	CcSEcCtD
Fentanyl—Arthritis—Thalidomide—leprosy	0.000598	0.00287	CcSEcCtD
Fentanyl—Cough—Dapsone—leprosy	0.000596	0.00287	CcSEcCtD
Fentanyl—Hypoglycaemia—Thalidomide—leprosy	0.000595	0.00286	CcSEcCtD
Fentanyl—Lethargy—Thalidomide—leprosy	0.000593	0.00285	CcSEcCtD
Fentanyl—Hyponatraemia—Thalidomide—leprosy	0.000583	0.0028	CcSEcCtD
Fentanyl—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000581	0.00279	CcSEcCtD
Fentanyl—Pain in extremity—Thalidomide—leprosy	0.000581	0.00279	CcSEcCtD
Fentanyl—Osteoarthritis—Thalidomide—leprosy	0.000581	0.00279	CcSEcCtD
Fentanyl—Disturbance in sexual arousal—Thalidomide—leprosy	0.000576	0.00277	CcSEcCtD
Fentanyl—Affect lability—Thalidomide—leprosy	0.000572	0.00275	CcSEcCtD
Fentanyl—Psychotic disorder—Thalidomide—leprosy	0.000567	0.00273	CcSEcCtD
Fentanyl—Face oedema—Thalidomide—leprosy	0.000561	0.0027	CcSEcCtD
Fentanyl—Cardiac arrest—Thalidomide—leprosy	0.000552	0.00266	CcSEcCtD
Fentanyl—Mood swings—Thalidomide—leprosy	0.00055	0.00265	CcSEcCtD
Fentanyl—Tachycardia—Dapsone—leprosy	0.000544	0.00262	CcSEcCtD
Fentanyl—Dehydration—Thalidomide—leprosy	0.00054	0.0026	CcSEcCtD
Fentanyl—Orthostatic hypotension—Thalidomide—leprosy	0.000531	0.00255	CcSEcCtD
Fentanyl—Hypokalaemia—Thalidomide—leprosy	0.000529	0.00254	CcSEcCtD
Fentanyl—Breast disorder—Thalidomide—leprosy	0.000525	0.00252	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000523	0.00251	CcSEcCtD
Fentanyl—Muscular weakness—Thalidomide—leprosy	0.000512	0.00246	CcSEcCtD
Fentanyl—Abdominal distension—Thalidomide—leprosy	0.000506	0.00243	CcSEcCtD
Fentanyl—Insomnia—Dapsone—leprosy	0.000505	0.00242	CcSEcCtD
Fentanyl—Dysphagia—Thalidomide—leprosy	0.000502	0.00241	CcSEcCtD
Fentanyl—Influenza—Thalidomide—leprosy	0.000502	0.00241	CcSEcCtD
Fentanyl—Bronchospasm—Thalidomide—leprosy	0.000494	0.00237	CcSEcCtD
Fentanyl—Angina pectoris—Thalidomide—leprosy	0.000489	0.00235	CcSEcCtD
Fentanyl—Bronchitis—Thalidomide—leprosy	0.000483	0.00232	CcSEcCtD
Fentanyl—Pancytopenia—Thalidomide—leprosy	0.000477	0.00229	CcSEcCtD
Fentanyl—Neutropenia—Thalidomide—leprosy	0.00047	0.00226	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Thalidomide—leprosy	0.000467	0.00224	CcSEcCtD
Fentanyl—Pollakiuria—Thalidomide—leprosy	0.000464	0.00223	CcSEcCtD
Fentanyl—Erectile dysfunction—Thalidomide—leprosy	0.000463	0.00222	CcSEcCtD
Fentanyl—Weight increased—Thalidomide—leprosy	0.000457	0.0022	CcSEcCtD
Fentanyl—Gastrointestinal pain—Dapsone—leprosy	0.000456	0.00219	CcSEcCtD
Fentanyl—Weight decreased—Thalidomide—leprosy	0.000454	0.00218	CcSEcCtD
Fentanyl—Hyperglycaemia—Thalidomide—leprosy	0.000453	0.00218	CcSEcCtD
Fentanyl—Pneumonia—Thalidomide—leprosy	0.00045	0.00216	CcSEcCtD
Fentanyl—Infestation—Thalidomide—leprosy	0.000448	0.00215	CcSEcCtD
Fentanyl—Drowsiness—Thalidomide—leprosy	0.000448	0.00215	CcSEcCtD
Fentanyl—Infestation NOS—Thalidomide—leprosy	0.000448	0.00215	CcSEcCtD
Fentanyl—Depression—Thalidomide—leprosy	0.000446	0.00215	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000444	0.00213	CcSEcCtD
Fentanyl—Abdominal pain—Dapsone—leprosy	0.000441	0.00212	CcSEcCtD
Fentanyl—Body temperature increased—Dapsone—leprosy	0.000441	0.00212	CcSEcCtD
Fentanyl—Renal failure—Thalidomide—leprosy	0.00044	0.00212	CcSEcCtD
Fentanyl—Neuropathy peripheral—Thalidomide—leprosy	0.000439	0.00211	CcSEcCtD
Fentanyl—Stomatitis—Thalidomide—leprosy	0.000436	0.0021	CcSEcCtD
Fentanyl—Conjunctivitis—Thalidomide—leprosy	0.000435	0.00209	CcSEcCtD
Fentanyl—Sweating—Thalidomide—leprosy	0.000429	0.00206	CcSEcCtD
Fentanyl—Haematuria—Thalidomide—leprosy	0.000427	0.00205	CcSEcCtD
Fentanyl—Epistaxis—Thalidomide—leprosy	0.000422	0.00203	CcSEcCtD
Fentanyl—Sinusitis—Thalidomide—leprosy	0.00042	0.00202	CcSEcCtD
Fentanyl—Bradycardia—Thalidomide—leprosy	0.000409	0.00197	CcSEcCtD
Fentanyl—Rhinitis—Thalidomide—leprosy	0.000403	0.00194	CcSEcCtD
Fentanyl—Hypoaesthesia—Thalidomide—leprosy	0.0004	0.00192	CcSEcCtD
Fentanyl—Pharyngitis—Thalidomide—leprosy	0.000399	0.00192	CcSEcCtD
Fentanyl—Urinary tract disorder—Thalidomide—leprosy	0.000397	0.00191	CcSEcCtD
Fentanyl—Oedema peripheral—Thalidomide—leprosy	0.000396	0.0019	CcSEcCtD
Fentanyl—Urethral disorder—Thalidomide—leprosy	0.000394	0.00189	CcSEcCtD
Fentanyl—Visual impairment—Thalidomide—leprosy	0.000387	0.00186	CcSEcCtD
Fentanyl—Erythema multiforme—Thalidomide—leprosy	0.00038	0.00183	CcSEcCtD
Fentanyl—Eye disorder—Thalidomide—leprosy	0.000376	0.00181	CcSEcCtD
Fentanyl—Tinnitus—Thalidomide—leprosy	0.000375	0.0018	CcSEcCtD
Fentanyl—Cardiac disorder—Thalidomide—leprosy	0.000373	0.00179	CcSEcCtD
Fentanyl—Angiopathy—Thalidomide—leprosy	0.000365	0.00175	CcSEcCtD
Fentanyl—Immune system disorder—Thalidomide—leprosy	0.000363	0.00174	CcSEcCtD
Fentanyl—Mediastinal disorder—Thalidomide—leprosy	0.000362	0.00174	CcSEcCtD
Fentanyl—Chills—Thalidomide—leprosy	0.000361	0.00173	CcSEcCtD
Fentanyl—Arrhythmia—Thalidomide—leprosy	0.000359	0.00173	CcSEcCtD
Fentanyl—Alopecia—Thalidomide—leprosy	0.000355	0.00171	CcSEcCtD
Fentanyl—Vomiting—Dapsone—leprosy	0.000355	0.0017	CcSEcCtD
Fentanyl—Mental disorder—Thalidomide—leprosy	0.000352	0.00169	CcSEcCtD
Fentanyl—Malnutrition—Thalidomide—leprosy	0.00035	0.00168	CcSEcCtD
Fentanyl—Headache—Dapsone—leprosy	0.000349	0.00168	CcSEcCtD
Fentanyl—Flatulence—Thalidomide—leprosy	0.000345	0.00166	CcSEcCtD
Fentanyl—Tension—Thalidomide—leprosy	0.000343	0.00165	CcSEcCtD
Fentanyl—Dysgeusia—Thalidomide—leprosy	0.000343	0.00165	CcSEcCtD
Fentanyl—Nervousness—Thalidomide—leprosy	0.00034	0.00163	CcSEcCtD
Fentanyl—Back pain—Thalidomide—leprosy	0.000338	0.00163	CcSEcCtD
Fentanyl—Muscle spasms—Thalidomide—leprosy	0.000336	0.00162	CcSEcCtD
Fentanyl—Nausea—Dapsone—leprosy	0.000331	0.00159	CcSEcCtD
Fentanyl—Vision blurred—Thalidomide—leprosy	0.00033	0.00158	CcSEcCtD
Fentanyl—Tremor—Thalidomide—leprosy	0.000328	0.00158	CcSEcCtD
Fentanyl—Ill-defined disorder—Thalidomide—leprosy	0.000325	0.00156	CcSEcCtD
Fentanyl—Anaemia—Thalidomide—leprosy	0.000323	0.00155	CcSEcCtD
Fentanyl—Agitation—Thalidomide—leprosy	0.000322	0.00155	CcSEcCtD
Fentanyl—Malaise—Thalidomide—leprosy	0.000316	0.00152	CcSEcCtD
Fentanyl—Vertigo—Thalidomide—leprosy	0.000314	0.00151	CcSEcCtD
Fentanyl—Syncope—Thalidomide—leprosy	0.000314	0.00151	CcSEcCtD
Fentanyl—Leukopenia—Thalidomide—leprosy	0.000313	0.00151	CcSEcCtD
Fentanyl—Palpitations—Thalidomide—leprosy	0.000309	0.00149	CcSEcCtD
Fentanyl—Loss of consciousness—Thalidomide—leprosy	0.000308	0.00148	CcSEcCtD
Fentanyl—Cough—Thalidomide—leprosy	0.000305	0.00147	CcSEcCtD
Fentanyl—Convulsion—Thalidomide—leprosy	0.000303	0.00146	CcSEcCtD
Fentanyl—Hypertension—Thalidomide—leprosy	0.000302	0.00145	CcSEcCtD
Fentanyl—Arthralgia—Thalidomide—leprosy	0.000298	0.00143	CcSEcCtD
Fentanyl—Chest pain—Thalidomide—leprosy	0.000298	0.00143	CcSEcCtD
Fentanyl—Myalgia—Thalidomide—leprosy	0.000298	0.00143	CcSEcCtD
Fentanyl—Anxiety—Thalidomide—leprosy	0.000297	0.00143	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000296	0.00142	CcSEcCtD
Fentanyl—Discomfort—Thalidomide—leprosy	0.000294	0.00141	CcSEcCtD
Fentanyl—Dry mouth—Thalidomide—leprosy	0.000291	0.0014	CcSEcCtD
Fentanyl—Confusional state—Thalidomide—leprosy	0.000288	0.00138	CcSEcCtD
Fentanyl—Oedema—Thalidomide—leprosy	0.000286	0.00137	CcSEcCtD
Fentanyl—Infection—Thalidomide—leprosy	0.000284	0.00136	CcSEcCtD
Fentanyl—Shock—Thalidomide—leprosy	0.000281	0.00135	CcSEcCtD
Fentanyl—Nervous system disorder—Thalidomide—leprosy	0.00028	0.00135	CcSEcCtD
Fentanyl—Thrombocytopenia—Thalidomide—leprosy	0.00028	0.00134	CcSEcCtD
Fentanyl—Tachycardia—Thalidomide—leprosy	0.000279	0.00134	CcSEcCtD
Fentanyl—Skin disorder—Thalidomide—leprosy	0.000277	0.00133	CcSEcCtD
Fentanyl—Hyperhidrosis—Thalidomide—leprosy	0.000276	0.00133	CcSEcCtD
Fentanyl—Anorexia—Thalidomide—leprosy	0.000272	0.00131	CcSEcCtD
Fentanyl—Hypotension—Thalidomide—leprosy	0.000267	0.00128	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Thalidomide—leprosy	0.00026	0.00125	CcSEcCtD
Fentanyl—Insomnia—Thalidomide—leprosy	0.000258	0.00124	CcSEcCtD
Fentanyl—Paraesthesia—Thalidomide—leprosy	0.000256	0.00123	CcSEcCtD
Fentanyl—Dyspnoea—Thalidomide—leprosy	0.000255	0.00122	CcSEcCtD
Fentanyl—Somnolence—Thalidomide—leprosy	0.000254	0.00122	CcSEcCtD
Fentanyl—Dyspepsia—Thalidomide—leprosy	0.000251	0.00121	CcSEcCtD
Fentanyl—Decreased appetite—Thalidomide—leprosy	0.000248	0.00119	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Thalidomide—leprosy	0.000247	0.00118	CcSEcCtD
Fentanyl—Fatigue—Thalidomide—leprosy	0.000246	0.00118	CcSEcCtD
Fentanyl—Pain—Thalidomide—leprosy	0.000244	0.00117	CcSEcCtD
Fentanyl—Constipation—Thalidomide—leprosy	0.000244	0.00117	CcSEcCtD
Fentanyl—Feeling abnormal—Thalidomide—leprosy	0.000235	0.00113	CcSEcCtD
Fentanyl—Gastrointestinal pain—Thalidomide—leprosy	0.000234	0.00112	CcSEcCtD
Fentanyl—Urticaria—Thalidomide—leprosy	0.000227	0.00109	CcSEcCtD
Fentanyl—Abdominal pain—Thalidomide—leprosy	0.000226	0.00108	CcSEcCtD
Fentanyl—Body temperature increased—Thalidomide—leprosy	0.000226	0.00108	CcSEcCtD
Fentanyl—Hypersensitivity—Thalidomide—leprosy	0.00021	0.00101	CcSEcCtD
Fentanyl—Asthenia—Thalidomide—leprosy	0.000205	0.000985	CcSEcCtD
Fentanyl—Pruritus—Thalidomide—leprosy	0.000202	0.000971	CcSEcCtD
Fentanyl—Diarrhoea—Thalidomide—leprosy	0.000195	0.000939	CcSEcCtD
Fentanyl—Dizziness—Thalidomide—leprosy	0.000189	0.000908	CcSEcCtD
Fentanyl—Vomiting—Thalidomide—leprosy	0.000182	0.000873	CcSEcCtD
Fentanyl—Rash—Thalidomide—leprosy	0.00018	0.000865	CcSEcCtD
Fentanyl—Dermatitis—Thalidomide—leprosy	0.00018	0.000865	CcSEcCtD
Fentanyl—Headache—Thalidomide—leprosy	0.000179	0.00086	CcSEcCtD
Fentanyl—Nausea—Thalidomide—leprosy	0.00017	0.000815	CcSEcCtD
